Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium channel protein type T antagonists are compounds that block low-voltage activated Ca²⁺ entry through Cav3.x subfamily channels—modulating key physiological processes like neuronal firing and vascular tone—and have therapeutic potential especially for neurological disorders such as epilepsy and chronic pain syndromes.
Inhibition of Ca²⁺ influx through T-type calcium channels
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium channel protein type T.